3.73% -0.0235

Vistagen Therapeutics Inc (VTGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Vistagen Therapeutics Inc Azioni (VTGN) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	17.44% 0.303	0.258	0.244	-0.015	0.234
Operating Expenses	2.27% 19.85	20.31	16.05	14.48	15.35
Benefits Costs and Expenses	2.40% 19.20	19.68	15.34	13.62	14.32
Costs And Expenses	2.40% 19.20	19.68	15.34	13.62	14.32
Operating Income/Loss	2.53% -19.55	-20.05	-15.80	-14.49	-15.12
Income/Loss From Continuing Operations Before Tax	2.67% -18.90	-19.42	-15.10	-13.63	-14.09
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	2.67% -18.90	-19.42	-15.10	-13.63	-14.09
Net Income/Loss	2.67% -18.90	-19.42	-15.10	-13.63	-14.09
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	18.14% 42.23	35.75	31.93	0.2276	30.71
Diluted Average Shares	18.14% 42.23	35.75	31.93	0.2276	30.71
Basic Earnings Per Share	16.67% -0.45	-0.54	-0.47	-0.44	-0.46
Diluted Earnings Per Share	16.67% -0.45	-0.54	-0.47	-0.44	-0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%